EUVIMEDEUVIMED entdecken
Open Access

National and Provincial Lifetime Risk of Chronic Respiratory Disease — China, 2023

Qian Mao, Zhenping Zhao, Maigeng Zhou

China CDC Weekly · 2026 · 8 (22) · 693-701

DOI: 10.46234/ccdcw2026.112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift China CDC Weekly, 2026. Verfasst von Qian Mao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan City, Shandong Province, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic respiratory disease (CRD) ranks among the leading causes of morbidity and mortality in China, representing a major public health challenge.Despite this substantial disease burden, the lifetime risk (LTR) of developing CRD in the Chinese population remains poorly characterized.This study systematically estimates the LTR of CRD at both the national level and across all 31 provincial-level administrative divisions (PLADs) in China from 1990 to 2023.

Methods

We estimated CRD-related LTRs across China and its 31 PLADs by age, sex, and year, incorporating CRD incidence hazard, CRD-deleted mortality, and CRD-free survival probability derived from incidence, prevalence, and mortality rates.All data were obtained from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023.

Results

In 2023, the overall LTR of CRD reached 61.30% [95% uncertainty interval (UI): 47.36, 76.91], a 13.69% (95% UI: 21.03, 63.69) increase from 1990.Males exhibited higher risk 62.13%( 95% UI: 49.01, 77.25) than females 60.21%(95% UI: 47.06, 74.92), and the LTR declined with increasing age at diagnosis.Marked geographic heterogeneity emerged, with the western and southwestern regions bearing the highest burden and the northeastern region demonstrating the lowest risk.

Conclusion

The LTR of CRD in China has risen substantially since 1990, with marked regional heterogeneity.These geographic disparities underscore the need for precision public health interventions and region-specific resource allocation to effectively curb the rising trajectory of CRD.Chronic respiratory disease (CRD) remains a critical public health challenge in China, ranking as a major global cause of mortality and morbidity and affecting nearly 100 million adults with COPD alone (1-2).In response to this escalating burden, the Chinese government has introduced landmark strategies, notably the "Healthy China 2030" blueprint and the "National Medium-to-Long-term Plan for the Prevention and Treatment of Chronic Diseases (2017)(2018)(2019)(2020)(2021)(2022)(2023)(2024)(2025)."These initiatives mandate specific interventions, including integrating pulmonary function testing into routine physical examinations, enforcing stricter tobacco control regulations, and expanding community-based management for respiratory patients (3-4).Despite these concerted efforts, the sheer scale of the affected population underscores the urgent need for intuitive, populationlevel indicators to monitor long-term epidemiological trajectories and evaluate policy efficacy.Lifetime risk (LTR), a key measure of population disease burden, represents the probability that a disease-free individual will develop a specific condition over the remainder of their life (5).This metric offers critical insights into prospective healthcare demands, making it invaluable for long-term policy formulation (6).As a standardized measure, LTR also facilitates robust comparisons of disease risk across population subgroups, thereby revealing health disparities and guiding targeted public health interventions.Despite this significant disease burden, research quantifying CRD burden in China from the LTR perspective remains limited, with most existing studies focusing on national-level trends from earlier GBD cycles.To bridge this knowledge gap, the present study provides a more granular estimation of the LTR of CRD across 31 PLADs, utilizing the newly released GBD 2023.By independently calculating spatiotemporal trends and accounting for competing risks of death, this research distinguishes itself from prior national-scale assessments by revealing specific regional disparities and LTR transformations within the context of China's latest demographic and health transitions.

Schlagwörter

Stichwörter der Autor:innen

ChinaChronic Respiratory DiseaseGlobal Burden of DiseasesLifetime Risk

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan City, Shandong Province, China.
  • National Center for Chronic Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention & Chinese Academy of Preventive Medicine, Beijing, China.

Zitieren

APA

Mao, Q., Zhao, Z., & Zhou, M. (2026). National and Provincial Lifetime Risk of Chronic Respiratory Disease — China, 2023. China CDC Weekly, 8(22), 693-701. https://doi.org/10.46234/ccdcw2026.112

Vancouver

Mao Q, Zhao Z, Zhou M. National and Provincial Lifetime Risk of Chronic Respiratory Disease — China, 2023. China CDC Weekly. 2026;8(22):693-701. doi:10.46234/ccdcw2026.112

BibTeX
@article{Mao2026,
  author = {Mao, Qian and Zhao, Zhenping and Zhou, Maigeng},
  title = {National and Provincial Lifetime Risk of Chronic Respiratory Disease — China, 2023},
  journal = {China CDC Weekly},
  year = {2026},
  volume = {8},
  number = {22},
  pages = {693--701},
  doi = {10.46234/ccdcw2026.112}
}
Kostenlos starten →